PetIQ (NASDAQ:PETQ) was upgraded by BidaskClub from a “sell” rating to a “hold” rating in a research note issued to investors on Tuesday, BidAskClub reports.

PETQ has been the topic of several other research reports. Zacks Investment Research raised shares of PetIQ from a “sell” rating to a “hold” rating in a research note on Wednesday, January 8th. Raymond James reaffirmed a “buy” rating on shares of PetIQ in a research report on Wednesday, December 4th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. PetIQ currently has a consensus rating of “Hold” and a consensus price target of $36.67.

PETQ traded up $0.82 on Tuesday, reaching $31.32. The stock had a trading volume of 10,336 shares, compared to its average volume of 240,314. The company has a current ratio of 2.67, a quick ratio of 1.45 and a debt-to-equity ratio of 0.82. The company has a market capitalization of $837.98 million, a price-to-earnings ratio of 24.75, a price-to-earnings-growth ratio of 0.88 and a beta of 1.94. PetIQ has a fifty-two week low of $21.28 and a fifty-two week high of $36.33. The firm has a 50-day moving average of $24.82 and a 200-day moving average of $28.15.

PetIQ (NASDAQ:PETQ) last posted its earnings results on Thursday, November 7th. The company reported $0.42 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.33 by $0.09. PetIQ had a negative net margin of 0.59% and a positive return on equity of 9.77%. The firm had revenue of $186.03 million for the quarter, compared to analyst estimates of $173.21 million. Sell-side analysts anticipate that PetIQ will post 0.98 EPS for the current fiscal year.

In other news, CFO John Newland bought 44,000 shares of the firm’s stock in a transaction on Tuesday, November 12th. The stock was acquired at an average price of $22.28 per share, with a total value of $980,320.00. Following the transaction, the chief financial officer now owns 44,000 shares of the company’s stock, valued at approximately $980,320. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Corporate insiders own 23.79% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of PETQ. AQR Capital Management LLC increased its position in shares of PetIQ by 4.0% during the second quarter. AQR Capital Management LLC now owns 9,620 shares of the company’s stock worth $317,000 after buying an additional 367 shares during the period. Envestnet Asset Management Inc. raised its position in shares of PetIQ by 2.6% in the 3rd quarter. Envestnet Asset Management Inc. now owns 28,163 shares of the company’s stock worth $768,000 after acquiring an additional 709 shares in the last quarter. Oppenheimer Asset Management Inc. raised its position in shares of PetIQ by 11.3% in the 3rd quarter. Oppenheimer Asset Management Inc. now owns 11,038 shares of the company’s stock worth $301,000 after acquiring an additional 1,121 shares in the last quarter. California State Teachers Retirement System raised its position in shares of PetIQ by 4.0% in the 3rd quarter. California State Teachers Retirement System now owns 30,233 shares of the company’s stock worth $824,000 after acquiring an additional 1,161 shares in the last quarter. Finally, Boston Partners lifted its stake in shares of PetIQ by 1.3% in the 2nd quarter. Boston Partners now owns 100,206 shares of the company’s stock valued at $3,302,000 after purchasing an additional 1,266 shares during the period. Hedge funds and other institutional investors own 99.74% of the company’s stock.

PetIQ Company Profile

PetIQ, Inc operates as a pet health and wellness company. It operates through two segments, Products and Services. It manufactures and distributes veterinarian services and veterinarian-grade pet products, including prescription (Rx) medications, over-the-counter (OTC) flea and tick preventatives, and health and wellness products for dogs and cats.

Featured Article: Portfolio Manager

Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.